Moleac Pte Ltd.
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.moleac.com
Clinical Trials
7
Active:1
Completed:4
Trial Phases
4 Phases
Phase 1:1
Phase 2:3
Phase 3:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (50.0%)Phase 1
1 (16.7%)Phase 3
1 (16.7%)Phase 4
1 (16.7%)CognivAiD Real-World Evidence Clinical Registry (CONNECT Registry)
Recruiting
- Conditions
- Memory ImpairmentDementia, Vascular
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06228638
- Locations
- 🇸🇬
Raffles Hospital, Singapore, Singapore
MLC1501 Study Assessing Efficacy in Post STrOke Subjects with MOtor Deficits
Phase 2
Active, not recruiting
- Conditions
- Strokes ThromboticStroke, IschemicStroke, EmbolicStroke, CryptogenicStrokeStroke, CardiovascularStroke Sequelae
- Interventions
- Other: Placebo
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT05289947
- Locations
- 🇵🇭
Baguio General Hospital and Medical Center, Baguio, Philippines
🇵🇭Metro Davao Medical And Research Center, Davao, Philippines
🇵🇭West Visayas State University Medical Center, Iloilo City, Philippines
MLC1501 Study Assessing Efficacy in STROke Recovery
Phase 2
Not yet recruiting
- Conditions
- StrokeStroke, CardiovascularStroke, CryptogenicStroke, EmbolicStroke, IschemicStrokes ThromboticStroke Sequelae
- Interventions
- Other: Placebo
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 540
- Registration Number
- NCT05046106
NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury
Phase 3
Completed
- Conditions
- Traumatic Brain Injury
- First Posted Date
- 2021-04-27
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 182
- Registration Number
- NCT04861688
- Locations
- 🇷🇺
Nizhny Novgorod regional clinical hospital named after N. A. Semashko, Nizhny Novgorod, Russian Federation
🇷🇺State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation
🇷🇺Municipal Polyclinic № 106 of St.Petersburg, Saint Petersburg, Russian Federation
Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects
Phase 1
Completed
- Conditions
- Stroke
- Interventions
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Moleac Pte Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT04233437
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
- Prev
- 1
- 2
- Next
News
No news found